摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

乙基-2-(羟基(2-(三氟甲基)苯基)甲基)丙烯酸酯 | 1019388-47-6

中文名称
乙基-2-(羟基(2-(三氟甲基)苯基)甲基)丙烯酸酯
中文别名
——
英文名称
ethyl 2-(hydroxy(2-(trifluoromethyl)phenyl)methyl)acrylate
英文别名
ethyl-2-(hydroxyl(2-(trifluoromethyl)phenyl)methyl)acrylate;ethyl 3-hydroxy-2-methylene-3-(2-trifluoromethylphenyl)propionate;Ethyl 2-[hydroxy-[2-(trifluoromethyl)phenyl]methyl]prop-2-enoate
乙基-2-(羟基(2-(三氟甲基)苯基)甲基)丙烯酸酯化学式
CAS
1019388-47-6
化学式
C13H13F3O3
mdl
——
分子量
274.24
InChiKey
HDUMFQCPJOBRQA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    19
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    乙基-2-(羟基(2-(三氟甲基)苯基)甲基)丙烯酸酯4-二甲氨基吡啶三乙胺β-isocupreidine 作用下, 以 乙二醇二甲醚二氯甲烷 为溶剂, 生成 ethyl (R)-2-((2-oxopyridin-1(2H)-yl)(2-(trifluoromethyl)phenyl)methyl)acrylate
    参考文献:
    名称:
    双功能路易斯碱催化 2-羟基吡啶的不对称 N-烯丙基烷基化
    摘要:
    记录了手性路易斯碱催化的 2-羟基吡啶和 MBH 碳酸酯的对映选择性N-烯丙基烷基化,提供了一种方便地获得N-烷基化 2-吡啶酮的途径,其 ee 高达 99%,产率高达 99%。实验和计算研究表明,手性路易斯碱催化剂与 2-羟基吡啶之间的强氢键相互作用对该反应的反应性、化学选择性和对映选择性起着至关重要的作用。
    DOI:
    10.1021/acs.orglett.2c03207
  • 作为产物:
    描述:
    2-三氟甲基苯甲醇丙烯酸乙酯硫酰氟potassium carbonate三乙烯二胺 作用下, 以 二甲基亚砜 为溶剂, 反应 48.0h, 以87%的产率得到乙基-2-(羟基(2-(三氟甲基)苯基)甲基)丙烯酸酯
    参考文献:
    名称:
    Design, synthesis and biological evaluation of novel arylpropionic esters for the treatment of acute kidney injury
    摘要:
    Acute kidney injury (AKI) is associated with a strong inflammatory response, and inhibiting the response effectively prevents or ameliorates AKI. A series of novel arylpropionic esters were designed, synthesized and evaluated their biological activity in LPS-stimulated RAW264.7 cells. Novel arylpropionic esters bearing multi-functional groups showed significant anti-inflammatory activity, in which, compound 13b exhibited the most potent activity through dose-dependent inhibiting the production of nitric oxide (NO, IC50 = 3.52 μM), TNF-α and IL-6 (84.1% and 33.6%, respectively), as well as suppressing the expression of iNOS, COX-2 and TLR4 proteins. In C57BL/6 mice with cisplatin-induced AKI, compound 13b improved kidney function, inhibited inflammatory development, and reduced pathological damage of kidney tissues. In brief, this arylpropionic ester scaffold may be developed as anti-inflammatory agents.
    DOI:
    10.1016/j.bioorg.2020.104455
点击查看最新优质反应信息

文献信息

  • INDOLIZINONE BASED DERIVATIVES AS POTENTIAL PHOSPHODIESTERASE 3 (PDE3) INHIBITORS AND A PROCESS FOR THE PREPARATION THEREOF
    申请人:COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    公开号:US20140296530A1
    公开(公告)日:2014-10-02
    The present invention provides compounds of general formula A useful as potential phosphodiesterase3 (PDE3) inhibitory agents and a process for the preparation thereof. The derivatives of formula A can be employed as therapeutics in human and veterinary medicine, where they can be used, for example, for the treatment and prophylaxis of the following diseases: heart failure, dilated cardiomyopathy, platelet inhibitors, cancer and obstructive pulmonary diseases.
    本发明提供了一般式A的化合物,作为潜在的磷酸二酯酶3(PDE3)抑制剂,并提供了其制备方法。一般式A的衍生物可用作人类和兽医药学中的治疗剂,例如可用于治疗和预防以下疾病:心力衰竭、扩张型心肌病、血小板抑制剂、癌症和阻塞性肺部疾病。
  • PYRIDOPYRIMIDINE BASED DERIVATIVES AS POTENTIAL PHOSPHODIESTERASE 3 (PDE3) INHIBITORS AND A PROCESS FOR THE PREPARATION THEREOF
    申请人:COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    公开号:US20140221651A1
    公开(公告)日:2014-08-07
    The present invention provides compounds of formula 1 as potential phosphodiesterase3 (PDE3) inhibitory agents and a process for the preparation thereof. The derivatives of formula 1 can be employed as therapeutics in human and veterinary medicine, where they can be used, for the treatment and prophylaxis of the following diseases: heart failure, dilated cardiomyopathy, platelet inhibitors, cancer and obstructive pulmonary diseases. Where in X=H, alkyl, aryl, heteroaryl Y=H, alkyl, aryl, heteroaryl R=substituted phenyl A=H, alkyl, alkoxy, halo, dihalo B=H, alkyl, alkoxy, halo, dihalo C=H, alkyl, alkoxy, halo, dihalo
    本发明提供了公式1的化合物作为潜在的磷酸二酯酶3(PDE3)抑制剂,并提供了其制备方法。公式1的衍生物可以作为人类和兽医药学中的治疗药物使用,用于治疗和预防以下疾病:心力衰竭、扩张型心肌病、血小板抑制剂、癌症和阻塞性肺部疾病。其中,X=H、烷基、芳基、杂环芳基;Y=H、烷基、芳基、杂环芳基;R=取代苯基;A=H、烷基、烷氧基、卤素、二卤代基;B=H、烷基、烷氧基、卤素、二卤代基;C=H、烷基、烷氧基、卤素、二卤代基。
  • PROCESS FOR PREPARATION OF INDOLIZINE BASED DERIVATIVES AS POTENTIAL PHOSPHODIESTRASE 3 (PDE3) INHIBITORS
    申请人:COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    公开号:US20160159792A1
    公开(公告)日:2016-06-09
    The present invention provides compounds of general formula 1 useful as potential phosphodiesterase3 (PDE3) inhibitory agents and a process for the preparation thereof. The derivatives of formula 1 can be employed as therapeutics in human and veterinary medicine, where they can be used, for example, for the treatment and prophylaxis of the following diseases: heart failure, dilated cardiomyopathy, platelet inhibitors, cancer and obstructive pulmonary diseases.
  • US9242982B2
    申请人:——
    公开号:US9242982B2
    公开(公告)日:2016-01-26
  • US9249139B2
    申请人:——
    公开号:US9249139B2
    公开(公告)日:2016-02-02
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫